In a murine model of breast cancer, hematopoietic and mesenchymal stromal cell sources of IL-15 are found to be dispensable for the maintenance and activity of ILC1s, while epithelial cancer cell-derived IL-15 is essential for ILC1s’ anti-tumour function [78]. Here, IL15 is linked to neoplasm.